Skip to content

Visual Prognosis in Non-Penetrating Corneal Blast Injuries

Visual Prognosis in Non-Penetrating Corneal Blast Injuries

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00414219
Enrollment
40
Registered
2006-12-21
Start date
2004-11-30
Completion date
2007-05-31
Last updated
2010-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Foreign Body Following Blast Injury

Brief summary

The purpose of this study is to assess visual quality of patients with non-penetrating, non-metallic, stable corneal foreign bodies. Visual quality will be assessed by examining visual acuity, wavefront analysis and contrast sensitivity. Drawings, photographs, and confocal microscopy will be used to document clinical examination of the cornea at baseline and on follow-up examinations.

Interventions

BEHAVIORALVisual quality of patients with corneal eye injuries

Visual quality of patients with corneal eye injuries

Sponsors

Walter Reed Army Medical Center
Lead SponsorFED

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * Access to medical care at Walter Reed Army Medical Center * Age 18 years or older * Corneal foreign bodies from blast injuries * Available for evaluation at Walter Reed

Exclusion criteria

* Residual, recurrent or active ocular disease in the designated eye as determined by exam and history. * Penetrating ocular trauma or injury to the posterior segment * Prior history of ocular surgery * Any physical or mental impairment that would preclude participation in any of the examinations. * Any ocular abnormality other than corneal foreign bodies that have any impact on vision (i.e. other abnormalities from trauma such as retinal detachment, corneal laceration, traumatic cataract, or abnormalities unrelated to trauma such as herpes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026